These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23350811)

  • 1. Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach.
    Schröder J; Klinger A; Oellien F; Marhöfer RJ; Duszenko M; Selzer PM
    J Med Chem; 2013 Feb; 56(4):1478-90. PubMed ID: 23350811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening approach for discovery of covalently bound ligands.
    Toledo Warshaviak D; Golan G; Borrelli KW; Zhu K; Kalid O
    J Chem Inf Model; 2014 Jul; 54(7):1941-50. PubMed ID: 24932913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
    Borišek J; Vizovišek M; Sosnowski P; Turk B; Turk D; Mohar B; Novič M
    J Med Chem; 2015 Sep; 58(17):6928-37. PubMed ID: 26280490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CovalentDock: automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints.
    Ouyang X; Zhou S; Su CT; Ge Z; Li R; Kwoh CK
    J Comput Chem; 2013 Feb; 34(4):326-36. PubMed ID: 23034731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dioxo-triazines as a novel series of cathepsin K inhibitors.
    Rankovic Z; Cai J; Fradera X; Dempster M; Mistry A; Mitchell A; Long C; Hamilton E; King A; Boucharens S; Jamieson C; Gillespie J; Cumming I; Uitdehaag J; van Zeeland M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1488-90. PubMed ID: 20153187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel docking of small-molecule libraries - Prospects to improve efficiency of lead compound discovery.
    Sarnpitak P; Mujumdar P; Taylor P; Cross M; Coster MJ; Gorse AD; Krasavin M; Hofmann A
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):941-7. PubMed ID: 26025037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular fields in ligand discovery.
    Gane PJ; Chan AW
    Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening for novel ligands.
    Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
    Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
    Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
    Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.
    Gozalbes R; Simon L; Froloff N; Sartori E; Monteils C; Baudelle R
    J Med Chem; 2008 Jun; 51(11):3124-32. PubMed ID: 18479119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening for lead discovery.
    Tang YT; Marshall GR
    Methods Mol Biol; 2011; 716():1-22. PubMed ID: 21318897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2012 Sep; 38():123-36. PubMed ID: 23079643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists.
    Yrjölä S; Kalliokoski T; Laitinen T; Poso A; Parkkari T; Nevalainen T
    Eur J Pharm Sci; 2013 Jan; 48(1-2):9-20. PubMed ID: 23131798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent docking of large libraries for the discovery of chemical probes.
    London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
    Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.